Global Regenerative Medicines Market
According to the report “Regenerative Medicines Market”, published by Market Data
Forecast, the global market is projected to reach USD 48.90 billion by 2021, at a CAGR of
23.24% from 2016 to 2021.
For full report refer to
http://www.marketdataforecast.com/market-reports/globalregenerative-medicines-market-272/
Regenerative medicines repair, replace or regenerate human cells, tissues, or organs affected
due to injury, disease, aging processes, congenital defects, and damage due to trauma. These
medicines restore normal functions of cells & tissues. These medicines are available in
different types such as genes, somatic cells, stem cells, and other types. Some of these
medicines (such as stem cells) have the ability to proliferate, differentiate thereby restore the
original structure of cells or tissues or organs. Regenerative medicines are used in varied range
of degenerative disorders include cardiovascular, neurodegenerative diseases, dermatology,
and orthopedic, among others. Majority of the researchers aim to focus on the development of
innovative technologies to provide better regenerative medicines and effective healthcare
treatment solutions to patients.
Free sample for the report is available at http://www.marketdataforecast.com/marketreports/global-regenerative-medicines-market-272/request-sample
Global regenerative medicines market is expected to witness growth owing to rising demand
for biologically derived materials for regenerative medicine, growing technological
advancements (nanotechnology based tissue engineering), and high support from government
to promote the tissue engineering for the development of advanced therapies. In addition,
growing utilization of regenerative medicines in cancer research & drug discovery, increasing
organ transplantations, and rising healthcare expenditure are further stimulating the growth of
global regenerative medicines market.
Global market for regenerative medicines is segmented on the basis of product, therapy, and
application
1) On the basis of Product
Cell-Based products
o Autologous Cell-Based Products
o Allogeneic Cell-Based Products
Acellular Products
2) On the basis of Therapy
Cell Therapy
Gene Therapy
Tissue Engineering
Immunotherapy
3) On the basis of Application
Orthopedic & Musculoskeletal Spine
Dermatology
+1 888-702-9626 | www.marketdataforecast.com | [email protected]